Global Orphan Drugs Industry Key Trends, Size, Growth, Shares And Forecast Research Report 2016

Researchmoz added Most up-to-date research on "Global Orphan Drugs Market Report: 2016 Edition" to its huge collection of research reports.

A rare disease is the one that occurs uncommonly or rarely in the general population.

However, there exists no clear definition for categorizing “rare diseases” and is usually defined on the basis of the prevalence, and some other factors including the severity of disease and availability of treatment options. Rare diseases are often serious, chronic and progressive. Orphan drugs are medicinal products intended for the diagnosis, prevention or treatment of rare diseases. These drugs are referred to be “orphan” as under normal conditions because these drugs are not cost effective to be developed by the pharmaceuticals industry, intended for a small number of patients suffering from rare conditions.

Increasing sales of prescription drugs, substantial benefits for new entrants in rare disease drug market, increased spending on medicines, rising healthcare expenditure and improving economic conditions of nations are some of the significant factors driving growth of the Orphan drugs market. However, the growth of the market is hindered by certain challenges including tougher regulatory approvals, limitation on charging higher prices and no approved drugs for several rare diseases including Polychethemia Vera (PV).

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=548106

The global orphan drugs market is expected to see numerous developments including approval of several Ultra-Rare drugs, increasing scope of Gene therapy, development of drugs for rare blood disease, higher success prospects for Hematology compared to Solid Tumors, attractive pricing option for orphan drug competitors and striking opportunities in developing orphan drugs.

The report, “Global Orphan Drugs Market” analyzes the current prevailing condition of the market along with its future scope of development. The global market along with specific market of the U.S., Canada, Europe and Japan, is being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.

Table of Content

1. Orphan Diseases: Introduction1.1 Causes
1.2 Prevention
1.3 Diagnosis
1.4 Treatment Options
1.5 Orphan Drugs

2. Market Analysis
2.1 Global Orphan Drugs Market

Market Value
Growth Rate
Market Segmentation

2.1.1 NonHodgkin’s Lymphoma (NHL) Market

3. Regional Analysis
3.1 The U.S. Orphan Drugs Market

Applications & Designations
Spending Growth Forecast

3.1.1 The UltraRare Drugs Market
3.2 Canada
3.3 Europe
3.4 Japan

4. Market Dynamics
4.1 Key Trends and Developments
4.1.1 Striking Opportunities in Developing Orphan Drugs
4.1.2 Attractive Pricing Option for Orphan Drug Companies
4.1.3 Higher Success Prospect for Hematology vs. Solid Tumors
4.1.4 Development of Drugs for Rare Blood Diseases
4.1.5 Increasing Scope of Gene Therapy
4.1.6 Approval of UltraOrphan Drugs
4.2 Growth Drivers
4.2.1 Increasing Sales of Prescription Drugs
4.2.2 Substantial Benefits for New Entrants in Rare Diseases Market
4.2.3 Increased Spending on Medicines
4.2.4 Rising Healthcare Expenditure
4.2.5 Rising Global GDP
4.3 Challenges
4.3.1 Limitation on Charging High Price for Orphan Drugs
4.3.2 No Approved Drug for Polycythemia Vera Firstline Treatment
4.3.3 Tough Regulatory Approval for Orphan Drugs

5. Competitive Landscape
5.1 Global Market

Market Share
Product Comparison

5.2 The U.S. Market

Market Share
Product Comparison

6. Company Profiles
6.1 Roche Holdings
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Novartis
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Celgene Corporation
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Novo Nordisk
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
6.5 Eli Lilly and Company
6.5.1 Business Overview
6.5.2 Financial Overview
6.5.3 Business Strategies

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=548106

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.